Pediatric Vilazodone Major Depression Disorder Trial

An open-label, 26 week, antidepressant therapy study of Vilazodone, a SSRI that has proven effective in treatment of MDD in adults.

We are currently recruiting:

  • Children and Adolescents, ages 7-17
  • Currently suffering from depression

Compensation: Yes

Contact:
utmooddisorders@uth.tmc.edu
713-486-2627


Pediatric Fetzima Major Depressive Disorder Trial

We are currently recruiting:

  • Children and Adolescents, ages 12-17
  • Currently suffering from depression

Compensation: Yes

Contact:
utmooddisorders@uth.tmc.edu
713-486-2627